HIGHLIGHTS
- who: Philip Broser from the (UNIVERSITY) have published the article: Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report, in the Journal: (JOURNAL)
- what: The authors report the case of a child with SGMRT1, in whom treatment with the JAK inhibitor ruxolitinib led to sustained clinical improvement. The authors report on a male patient who was born at term after an uncomplicated pregnancy to non-consanguineous parents.
SUMMARY
MDA5 recognizes viral double-stranded RNA (dsRNA) in the cytosol and upon ligand binding activates antiviral type I interferon-(IFN) signaling . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.